EPGFX Performance — EuroPac Gold Fund, Class A
Data updated: 2026-09-28
EPGFX returned −9.57% year to date and +41.25% over one year to Jul 2026. Annualised returns are +28.56% over 3 years and +12.69% over 5 years. Against its Europe Materials Equity category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $212, against $163 for the category, and to $141 over one year, against $172. Volatility over the past three years was 32.91% a year. In the 12 months to Jul 2026 the fund took in a net $79.2M, and assets reached $507.56M.
EPGFX Growth of $100
What $100 invested in EuroPac Gold Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Europe Materials Equity category average over the same months.
| Period | EPGFX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $141 | $172 |
| 3 years (Aug 2023 – Jul 2026) | $212 | $163 |
| 5 years (Aug 2021 – Jul 2026) | $182 | $149 |
| Since data start (Feb 2020 – Jul 2026) | $219 | $188 |
EPGFX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −9.57% |
| 1 year | +41.25% |
| 3 years (annualised) | +28.56% |
| 5 years (annualised) | +12.69% |
EPGFX Annual Returns
Calendar-year total returns of EuroPac Gold Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | −9.57% |
| 2025 | +129.04% |
| 2024 | +8.55% |
| 2023 | +2.31% |
| 2022 | −14.00% |
| 2021 | −18.04% |
| 2020 (Feb–Dec) | +35.35% |
EPGFX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +10.1% | +19.1% | −19.4% | −0.9% | +3.0% | −13.2% | −3.5% | — | — | — | — | — |
| 2025 | +9.9% | +3.1% | +10.5% | +8.4% | +2.6% | +5.2% | +0.1% | +20.1% | +16.1% | −6.7% | +15.2% | +4.1% |
| 2024 | −7.1% | −6.6% | +17.5% | +4.0% | +9.9% | −7.9% | +9.1% | −0.4% | +3.9% | +5.1% | −6.1% | −9.3% |
| 2023 | +9.6% | −11.5% | +17.8% | +1.8% | −7.7% | −3.1% | +4.0% | −5.9% | −9.5% | −0.7% | +11.1% | +0.6% |
| 2022 | −7.2% | +10.3% | +10.5% | −7.4% | −9.9% | −13.0% | −1.2% | −10.7% | 0.0% | +1.0% | +17.5% | +0.1% |
| 2021 | −6.1% | −9.5% | +1.7% | +5.4% | +12.5% | −13.3% | +0.3% | −6.4% | −8.7% | +10.2% | −3.4% | +1.0% |
| 2020 | — | −16.0% | −13.8% | +35.8% | +12.2% | +6.4% | +19.7% | +3.3% | −8.6% | −4.3% | −5.0% | +12.1% |
EPGFX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 32.91%
- 3-year Sharpe ratio: 0.73 (vs 4.5% risk-free rate)
- Best month: +20.12% (Aug 2025)
- Worst month: −19.42% (Mar 2026)
EPGFX Fund Flows
Monthly money in and out of EuroPac Gold Fund, from SEC Form N-PORT.
- 12-month net flow: $79.2M
- 12-month gross sales (incl. reinvestments): $252.0M
- Sales ÷ redemptions: 1.46×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.8M | $5.9M | −$1.2M |
| Jun 2026 | $6.6M | $9.3M | −$2.6M |
| May 2026 | $7.3M | $7.8M | −$501K |
| Apr 2026 | $5.6M | $10.2M | −$4.6M |
| Mar 2026 | $15.5M | $43.0M | −$27.5M |
| Feb 2026 | $28.3M | $24.5M | $3.8M |
| Jan 2026 | $60.6M | $20.3M | $40.4M |
| Dec 2025 | $45.7M | $17.2M | $28.5M |
| Nov 2025 | $6.1M | $7.7M | −$1.6M |
| Oct 2025 | $29.0M | $12.3M | $16.7M |
| Sep 2025 | $28.1M | $8.7M | $19.4M |
| Aug 2025 | $14.4M | $6.0M | $8.5M |
EPGFX Assets Under Management
Net assets of EuroPac Gold Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $507.56M |
| 2026-04-30 | $592.52M |
| 2026-01-31 | $649.49M |
| 2025-10-31 | $472.03M |
| 2025-07-31 | $328.04M |
| 2025-04-30 | $302.66M |
| 2025-01-31 | $230.93M |
| 2024-10-31 | $268.33M |
| 2024-07-31 | $247.06M |
| 2024-04-30 | $227.68M |
| 2024-01-31 | $197.75M |
| 2023-10-31 | $190.93M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.